SAVA: 50.88-2.18 (-4.11%) ... (after PRing it's best news yesterday)
AVXL: 13.06+0.70 (+5.66%)
Anavex's nice gain today on top of yesterday's gain on the new $25 target, and last week's $20 target by two WS firms.
TempPhil, another good day for Anavex considering all the markets and most stocks were in the red today.
It appears some SAVA funds are still moving into AVXL.
AVXL's market cap has a long way to go up to be in parity with SAVA's market cap. Especially considering AVXL's portfolio for numerous CNS disease indication vs SAVA's one trick pony that 'repairs' an Alzheimer problem down stream from AVXL's 2-71 Blarcamesine that stops the problem upstream before it can form in the first place, making SAVA's drug redundant and not needed.